Arrakis Therapeutics工商信息_电话_地址_信用信息_财务信息

公司简介

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines. Our goal is to interrogate and exploit the vast and largely unexplored transcriptome—the full collection of RNAs transcribed from DNA—to discover small-molecule medicines that target RNA at key disease intervention points.

主要成员

Daniel E. Koerwer、Michael Gilman、James Barsoum、Russell C. Petter

产品/服务

科技服务

TRYST and PEARL-seq Platforms

enable re-architecting drug discovery for RNA targets。

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2017-03	Henri Termeer、Osage University Partners、Celgene、Pfizer、Advent Life Sciences	3800万美元

关联公司